2023 Winners announced! Congratulations!

WINNER!

THE WEB MARKETING ASSOCIATION IS PROUD TO PRESENT THIS 2023 MOBILEWEBAWARD FOR OUTSTANDING ACHIEVEMENT IN MOBILE DEVELOPMENT

Bookmark and Share

image of Novo Nordisk, Inc.  Wins 2023 Best Medical Mobile Website Mobile WebAward for Novo Nordisk, Inc.

To: Novo Nordisk, Inc.

For: Novo Nordisk, Inc.

Award: Best Medical Mobile Website

Click here to see entry creative

About the Entry



Imagine you’re a doctor looking for information on a treatment, a resource for your patient, or more clinical education. You’re likely navigating between 3 to 4 completely different websites just to get that task done. novoMEDLINK is everything HCPs need. All in one place. It provides a better customer experience and creates internal efficiencies that mean spending less on maintenance and more on innovation. It's more data-driven, more personalized, and more effective. The new site includes: -Help prescribing–including product information across all therapeutic areas, sample ordering, patient education and insurance coverage information, all presented inside a single, consistent, easy-to-use interface. -Professional Education–with clinical training, treatment guidelines and other professional resources. -Patient Support–including a comprehensive library of both product education and disease education materials which are available for immediate download or complimentary office delivery. During usability testing physicians and their support staff provided overwhelmingly positive feedback: -In just 6 months, novoMEDLINK has provided a marked increase in engagement from HCP customers, including: -A 50% increase in pages per session. -A bounce rate improvement of 20 points. -Increased conversion rates and usage of resources. -And 35,000 incremental users to brand-specific pages. NovoMEDLINK provides a more effective customer service experience by leveraging data, saving medical professionals time¬–so they can better service their patients. At the end of the day, that’s what Novo Nordisk is here to do.